Condition
Aplastic Anemias
Total Trials
3
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 3 (1)
Trial Status
Not Yet Recruiting2
Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07227155Not Yet RecruitingPrimary
The HOPE Biobank Resource (BMT CTN 2402 HOPE)
NCT06650553Not ApplicableRecruitingPrimary
Umbilical Cord Blood-Supported Haplo-HSCT for Aplastic Anemia Treatment Study
NCT07001397Phase 3Not Yet RecruitingPrimary
Study on the Short-term Efficacy and Safety of Recombinant Human Thrombopoietin Combined With Immunosuppressant Sequential Eltrombopag Ethanolamine Dry Suspension in the Treatment of SAA/TD-NSAA
Showing all 3 trials